Woods, R., Schneider, D., Winkworth, C
126,127,128,129,130 Recent innovations, such as Gastric Per-Oral Endoscopic Myotomy (G-POEM) for refractory gastroparesis and advancements in enteric nervous system research, aim for targeted therapies
Although CEO Albert Bourla believes recent acquisitions including most notably the 2023 Seagen purchase have brought in about $20bn in 2030 risk-adjusted revenues, the company is unlikely to report dazzling growth in 2025
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
Chris Serres: They have found that in some cases, people that have been compulsive gamblers have found that their desire or craving for gambling has diminished significantly
Its clean formulation supports endurance, fat metabolism, and post-workout recovery while allowing easy dosage control